跳至主要内容
临床试验/NCT05842239
NCT05842239招募中不适用

Hyperbaric Oxygen Therapy for Men Suffering From Infertility Due to Oligospermia: a Pilot Study

Assaf-Harofeh Medical Center2 个研究点 分布在 1 个国家目标入组 15 人开始时间: 2024年1月20日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
招募中
入组人数
15
试验地点
2
主要终点
Sperm count

研究概览

简要总结

Infertility in a couple is defined as the inability to achieve conception despite one year of frequent, unprotected intercourse. Infertility affects approximately 12% of couples attempting to conceive. The goal of this study is to explore the potential beneficial effect of HBOT on sperm count of infertile male due to oligospermia.

详细描述

Infertility in a couple is defined as the inability to achieve conception despite one year of frequent, unprotected intercourse. Infertility affects approximately 12% of couples attempting to conceive. The male factor is equally attribute to couple infertility like woman infertility.

Male infertil¬ity may have many reasons. In up to 90% of male infertility cases, there is a decrease in sperm count or the might show poor sperm quality. During spermatogenesis, mitochondria undergo continuous morphological and distributional changes with germ cell development. Deficiencies in these processes lead to mitochondrial dysfunction and abnormal spermatogenesis, thereby causing male infertility.

In addition to mitochondria, telomer also play a significant role in sperm functionality. Telomere length is considered one of the most relevant biological markers of genomic stability. The negative impact of telomere shortening on sperm quality has been suggested as an important indicator of male infertility.

It is now understood that Hyperbaric oxygen treatment (HBOT), triggers both oxygen and pressure sensitive genes, resulting in inducing mitochondrial proliferation, increase in complex I activity and those mitochondrial efficiency. With respect to telomers, in a recent study, it was demonstrated that HBOT can induce telomeres elongation.

The goal of this study is to explore the potential beneficial effect of HBOT on sperm count of infertile male due to oligospermia.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
21 Years 至 —(Adult, Older Adult)
性别
Male
接受健康志愿者

入选标准

  • Age above 21 years
  • At least two sperm examination showing oligospermia (<15·106 sperm/mL)
  • Diagnosis of idiopathic oligospermia.
  • Subject willing and able to read, understand and sign an informed consent

排除标准

  • Inability to attend scheduled clinic visits and/or comply with the study protocol
  • Active malignancy
  • Previous treatment with chemotherapy and/or radiation therapy
  • Substance use at baseline
  • Severe or unstable physical disorders or major cognitive deficits at baseline
  • HBOT for any reason prior to study enrolment
  • Chest pathology incompatible with pressure changes (including moderate to severe asthma)
  • Ear or Sinus pathology incompatible with pressure changes
  • Chronic disease like diabetes mellitus, ischemic heart disease etc.
  • Active smoking

研究组 & 干预措施

Hyperbaric Oxygen Therapy active arm

Experimental

The protocol comprises of 60 consecutive hyperbaric oxygen treatment (HBOT) sessions, 5 sessions per week within a three months' period.

干预措施: Hyperbaric oxygen therapy (Device)

结局指标

主要结局

Sperm count

时间窗: At baseline, 3 months

Change from baseline in sperm count measured by Sperm Analysis

次要结局

  • Sperm count(9 months)
  • Sperm morphology(At baseline, 3 months, 9 months)
  • Sperm motility(At baseline, 3 months, 9 months)
  • Sperm telomeres length(At baseline, 3 months, 9 months)
  • Lymphocyte telomeres length(At baseline, 3 months, 9 months)

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Shay Efrati

MD

Assaf-Harofeh Medical Center

研究点 (2)

Loading locations...

相似试验